Skip Navigation
Narrow By
Safety Target
< All
1 - 20 of 79
STUDY
Medication errors in the home: a multisite study of children with cancer.
Walsh KE, Roblin DW, Weingart SN, et al. Pediatrics. 2013;131:e1405-e1414.
STUDY
Checking it twice: an evaluation of checklists for detecting medication errors at the bedside using a chemotherapy model.
White RE, Trbovich PL, Easty AC, Savage P, Trip K, Hyland S. Qual Saf Health Care. 2010;19:562-567.
ORGANIZATIONAL POLICY/GUIDELINES
American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards.
Jacobson JO, Polovich M, McNiff KK, et al; American Society of Clinical Oncology; Oncology Nursing Society. Oncol Nurs Forum. 2009;36:651-658.
STUDY
Using CPOE to improve communication, safety, and policy compliance when ordering pediatric chemotherapy.
Crossno CL, Cartwright JA, Hargrove FR. Hosp Pharm. 2007;42:368–373.
STUDY
Medication errors involving oral chemotherapy.
Weingart SN, Toro J, Spencer J, et al. Cancer. 2010;116:2455-2464.
STUDY
Characteristics of pediatric chemotherapy medication errors in a national error reporting database.
Rinke ML, Shore AD, Morlock L, Hicks RW, Miller MR. Cancer. 2007;110:186-195.
NEWSPAPER/MAGAZINE ARTICLE
IV vincristine survey shows safety improvements needed.
ISMP Medication Safety Alert! Acute Care Edition. February 23, 2006;11:1-2.
NEWSPAPER/MAGAZINE ARTICLE
Eric Cropp weighs in on the error that sent him to prison.
ISMP Medication Safety Alert! Acute Care Edition. December 3, 2009;14:1-3.
BOOK/REPORT
Fluorouracil Incident Root Cause Analysis Report.
Toronto, ON, Canada: Institute for Safe Medication Practices Canada. May 8, 2007.
COMMENTARY
Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine?
Reddy GK, Brown B, Nanda A. Clin Neurol Neurosurg. 2011;113:68-71.
STUDY
Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia.
Taylor JA, Winter L, Geyer LJ, Hawkins DS. Cancer. 2006;107:1400-1406.
STUDY
The impact of drug shortages on children with cancer—the example of mechlorethamine.
Metzger ML, Billett A, Link MP. N Engl J Med. 2012;367:2461-2463.
STUDY
Interruptions during the delivery of high-risk medications.
Trbovich P, Prakash V, Stewart J, Trip K, Savage P. J Nurs Adm. 2010;40:211-218.
STUDY
Oncology medication safety: a 3D status report 2008.
Johnson PE, Chambers CR, Vaida AJ. J Oncol Pharm Pract. 2008;14:169-180.
STUDY
Safety hazards in cancer care: findings using three different methods.
Lipczak H, Knudsen JL, Nissen A. BMJ Qual Saf. 2011;20:1052-1056.
1 2 3 4Next >